These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27670669)

  • 1. (±)-Gossypol induces apoptosis and autophagy in head and neck carcinoma cell lines and inhibits the growth of transplanted salivary gland cancer cells in BALB/c mice.
    Benvenuto M; Mattera R; Masuelli L; Taffera G; Andracchio O; Tresoldi I; Lido P; Giganti MG; Godos J; Modesti A; Bei R
    Int J Food Sci Nutr; 2017 May; 68(3):298-312. PubMed ID: 27670669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo.
    Masuelli L; Pantanella F; La Regina G; Benvenuto M; Fantini M; Mattera R; Di Stefano E; Mattei M; Silvestri R; Schippa S; Manzari V; Modesti A; Bei R
    Tumour Biol; 2016 Mar; 37(3):3705-17. PubMed ID: 26462840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
    Oliver CL; Bauer JA; Wolter KG; Ubell ML; Narayan A; O'Connell KM; Fisher SG; Wang S; Wu X; Ji M; Carey TE; Bradford CR
    Clin Cancer Res; 2004 Nov; 10(22):7757-63. PubMed ID: 15570010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2/Akt/FOXO3a signaling.
    Zhao GX; Xu LH; Pan H; Lin QR; Huang MY; Cai JY; Ouyang DY; He XH
    Oncotarget; 2015 Nov; 6(36):38952-66. PubMed ID: 26517515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells.
    Ko CH; Shen SC; Yang LY; Lin CW; Chen YC
    Int J Cancer; 2007 Oct; 121(8):1670-9. PubMed ID: 17597109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101.
    Masuelli L; Benvenuto M; Izzi V; Zago E; Mattera R; Cerbelli B; Potenza V; Fazi S; Ciuffa S; Tresoldi I; Lucarelli E; Modesti A; Bei R
    Invest New Drugs; 2020 Jun; 38(3):675-689. PubMed ID: 31264066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas.
    Masuelli L; Di Stefano E; Fantini M; Mattera R; Benvenuto M; Marzocchella L; Sacchetti P; Focaccetti C; Bernardini R; Tresoldi I; Izzi V; Mattei M; Frajese GV; Lista F; Modesti A; Bei R
    Oncotarget; 2014 Nov; 5(21):10745-62. PubMed ID: 25296980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PPARγ agonist rosiglitazone sensitizes the BH3 mimetic (-)-gossypol to induce apoptosis in cancer cells with high level of Bcl-2.
    Li X; He J; Li B; Gao M; Zeng Y; Lian J; Shi C; Huang Y; He F
    Mol Carcinog; 2018 Sep; 57(9):1213-1222. PubMed ID: 29856104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
    Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
    Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.
    Pang X; Wu Y; Wu Y; Lu B; Chen J; Wang J; Yi Z; Qu W; Liu M
    Mol Cancer Ther; 2011 May; 10(5):795-805. PubMed ID: 21372225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.
    Bauer JA; Trask DK; Kumar B; Los G; Castro J; Lee JS; Chen J; Wang S; Bradford CR; Carey TE
    Mol Cancer Ther; 2005 Jul; 4(7):1096-104. PubMed ID: 16020667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
    Shin D; Kim EH; Lee J; Roh JL
    Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2/Mcl-1 pathway.
    Sadahira K; Sagawa M; Nakazato T; Uchida H; Ikeda Y; Okamoto S; Nakajima H; Kizaki M
    Int J Oncol; 2014 Dec; 45(6):2278-86. PubMed ID: 25231749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu.
    Piechocki MP; Yoo GH; Dibbley SK; Amjad EH; Lonardo F
    Int J Cancer; 2006 Jul; 119(2):441-54. PubMed ID: 16470840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells.
    Masuelli L; Fantini M; Benvenuto M; Sacchetti P; Giganti MG; Tresoldi I; Lido P; Lista F; Cavallo F; Nanni P; Schlom J; Modesti A; Bei R
    J Transl Med; 2014 May; 12():122. PubMed ID: 24886178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
    Xin J; Zhan YH; Xia LM; Zhu HW; Nie YZ; Liang JM; Tian J
    Biomed Pharmacother; 2013 Feb; 67(1):88-95. PubMed ID: 23201009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells.
    Lin YL; Yuksel Durmaz Y; Nör JE; ElSayed ME
    Mol Pharm; 2013 Jul; 10(7):2730-8. PubMed ID: 23734725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells.
    Benvenuto M; Ciuffa S; Focaccetti C; Sbardella D; Fazi S; Scimeca M; Tundo GR; Barillari G; Segni M; Bonanno E; Manzari V; Modesti A; Masuelli L; Coletta M; Bei R
    Sci Rep; 2021 Sep; 11(1):19051. PubMed ID: 34561494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge.
    Melo G; Silva CAB; Hague A; Parkinson EK; Rivero ERC
    Oral Oncol; 2022 Sep; 132():105979. PubMed ID: 35816876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.